PubRank

T Mitsudomi

Author PubWeight™ 89.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998 3.20
2 Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 1990 2.97
3 Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res 1992 1.72
4 Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 2000 1.64
5 Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 1992 1.63
6 An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol 2012 1.63
7 Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer? Br J Cancer 2007 1.55
8 Inflammatory pseudotumor of the lung in adults: radiographic and clinicopathological analysis. Ann Thorac Surg 1989 1.53
9 Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations. J Natl Cancer Inst 1993 1.50
10 Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res 1999 1.47
11 High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene 1992 1.41
12 Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 1996 1.41
13 Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res 1990 1.33
14 Polymorphism at codon 213 within the p53 gene. Oncogene 1991 1.30
15 Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 2001 1.22
16 Carcinosarcoma and spindle cell carcinoma of the lung. Clinicopathologic and immunohistochemical studies. J Thorac Cardiovasc Surg 1990 1.20
17 Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J 2011 1.16
18 Mutations in the p53 gene in primary human breast cancers. Cancer Res 1991 1.15
19 Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol 2007 1.15
20 Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosomes Cancer 2000 1.15
21 A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1,630 cases. World J Surg 1989 1.13
22 Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 1991 1.09
23 Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res 1996 1.07
24 K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. Br J Cancer 1997 1.05
25 High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res 2000 1.04
26 Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 2001 1.04
27 Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas. Br J Cancer 2001 1.03
28 Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma. Chest 1995 0.98
29 Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene 1998 0.97
30 Malignant transformation of an intrathoracic neurofibroma in von Recklinghausen's disease. Scand Cardiovasc J 1998 0.97
31 Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib. Br J Cancer 2007 0.96
32 p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871. Chest 1994 0.96
33 p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res 1998 0.94
34 Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health 1995 0.94
35 Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation. Am J Pathol 2001 0.93
36 A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 1993 0.92
37 Molecular genetic characterization of neuroendocrine lung cancer cell lines. Anticancer Res 1995 0.92
38 Expression of human telomerase subunit genes in primary lung cancer and its clinical significance. Ann Thorac Surg 2000 0.91
39 Population-based mapping of pulmonary adenoma susceptibility 1 locus. Cancer Res 2000 0.91
40 Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res 1997 0.90
41 Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach. Oncogene 2007 0.90
42 Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest 1992 0.90
43 Surgical resection for pulmonary metastases of sweat gland carcinoma. Thorax 1994 0.89
44 Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann Thorac Surg 1997 0.89
45 MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence. Ann Thorac Surg 1999 0.89
46 Surgical treatment of lung cancer in the octogenarian. Ann Thorac Surg 1994 0.88
47 Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997 0.87
48 Increased levels of serum intercellular adhesion molecule-1 (ICAM-1) in patients with non-small cell lung cancer. Surg Oncol 1996 0.87
49 p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking. Br J Cancer 1998 0.87
50 Frequency of MAGE-3 gene expression in HLA-A2 positive patients with non-small cell lung cancer. Lung Cancer 1998 0.86
51 Frameshift mutations in TGFbetaRII, IGFIIR, BAX, hMSH3 and hMSH6 are absent in lung cancers. Carcinogenesis 1999 0.86
52 Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res 1997 0.86
53 Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. J Clin Invest 1992 0.85
54 Prognostic implication of transforming growth factor alpha in adenocarcinoma of the lung--an immunohistochemical study. Br J Cancer 1991 0.84
55 Prognostic value and clinicopathological correlation of thrombomodulin in squamous cell carcinoma of the human lung. Clin Cancer Res 1996 0.83
56 Giant hamartoma of the lung with a high production of carbohydrate antigen 19-9. Ann Thorac Surg 1993 0.83
57 Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines. Cancer Res 1996 0.83
58 N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Anticancer Res 1997 0.83
59 Invasive human fibrosarcoma DNA mediated induction of a 92 kDa gelatinase/type IV collagenase leads to an invasive phenotype. Biochem Biophys Res Commun 1991 0.83
60 Combined resections of the diaphragm and the liver for a locally advanced non-small-cell lung cancer. Respiration 1996 0.83
61 Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancers from Japanese patients and its association with squamous cell carcinoma. J Cancer Res Clin Oncol 1995 0.82
62 Polymorphism at codon 36 of the p53 gene. Oncogene 1994 0.82
63 Pulmonary dirofilariasis causing a solitary lung mass and pleural effusion. Thorax 1991 0.82
64 Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations. Oncogene 2012 0.81
65 Maximum length of tracheal autografts in dogs. J Thorac Cardiovasc Surg 1993 0.81
66 p53 mutations of lung cancer are not significantly affected by CYP1A1 or GSTM1 polymorphisms. Int J Oncol 1997 0.80
67 Angiosarcoma of the chest wall with a gastric metastasis. Thorac Cardiovasc Surg 1993 0.80
68 [Delayed traumatic hernia diagnosed with magnetic resonance imaging]. Nihon Kyobu Shikkan Gakkai Zasshi 1997 0.80
69 fos oncogene transfer to a transformed rat fibroblast cell line enhances spontaneous lung metastasis in rat. Jpn J Cancer Res 1986 0.80
70 Topographical distributions of allelic loss in individual non-small-cell lung cancers. Am J Pathol 2000 0.79
71 Effects of sodium n-butyrate on entry into S phase in resting rat 3Y1 cells infected with simian virus 40. J Virol 1985 0.79
72 Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro. Eur J Surg Oncol 1991 0.79
73 p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors. Int J Mol Med 1998 0.79
74 Selective cytotoxicity of phospholipids and diacylglycerols to rat 3Y1 fibroblasts transformed by adenovirus type 12 or its E1A gene. Cancer Res 1988 0.78
75 Hepatic inflow vessels caliber as an index for liver function. Hepatogastroenterology 1996 0.78
76 Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer. Biol Trace Elem Res 1994 0.78
77 Molecular biological markers and micrometastasis in resected non-small-cell lung cancer. Prognostic implications. Jpn J Thorac Cardiovasc Surg 2001 0.78
78 Time to first cigarette and lung cancer risk in Japan. Ann Oncol 2013 0.78
79 CT and MRI manifestations of primary pulmonary plasmacytoma. Clin Imaging 1995 0.78
80 Video-assisted thoracoscopic surgery of bullous and bleb disorders of the lung using endoscopic stapling device. Surg Laparosc Endosc 1995 0.78
81 Transformation by v-H-ras does not restore proliferation of a set of temperature-sensitive cell-cycle mutants of rat 3Y1 fibroblasts. Cell Struct Funct 1990 0.78
82 Estradiol sensitivity test using contact-sensitive plates of confluent BALB/c 3T3 cell monolayers. Cancer Res 1990 0.77
83 Thoracoscopy in the management of intrathoracic neurogenic tumors. Int Surg 1997 0.77
84 Abortive transformation of temperature-sensitive mutants of rat 3Y1 cells by simian virus 40: effect of cellular arrest states on entry into S phase and cellular proliferation. J Cell Physiol 1985 0.77
85 Identification of an epitope from the epithelial cell adhesion molecule eliciting HLA-A*2402-restricted cytotoxic T-lymphocyte responses. Tissue Antigens 2004 0.77
86 Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance. Lung Cancer 1994 0.77
87 A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204). Br J Cancer 2008 0.76
88 Large cell carcinoma of the lung. Prognostic implications of histopathologic and immunohistochemical subtyping. Am J Clin Pathol 1990 0.76
89 [Serum levels of c-erbB-2 protein in patients with lung adenocarcinoma: preliminary report]. Nihon Geka Gakkai Zasshi 1993 0.75
90 Identifying patients with peripheral-type early non-small cell lung cancer (T1N0M0) for whom irradiation of the primary focus alone could lead to successful treatment. Br J Radiol 2008 0.75
91 Successful management of tracheo-innominate artery fistula using interposition of a thymus pedicle flap. J Laryngol Otol 1995 0.75
92 Different chemosensitivities of rat 3Y1 fibroblasts transformed by various agents in vitro. Anticancer Res 1991 0.75
93 Characteristics of non-small cell lung cancer 3 cm or less in diameter. J Surg Oncol 1995 0.75
94 [Surgical problems encountered in cases of S0 (serosal invasion-free) gastric cancers]. Gan No Rinsho 1988 0.75
95 Papillary carcinoma in a huge intrathoracic goiter with tracheal stenosis and invasion. Case report. Scand J Thorac Cardiovasc Surg 1993 0.75
96 Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer. Surg Oncol 1995 0.75
97 DNA polymerase-alpha as a putative early relapse marker in non-small cell lung cancer. An immunohistochemical study. Cancer 1991 0.75
98 Adenocarcinoma and squamous cell carcinoma in the same lobe of the lung. A case report. Respiration 1991 0.75
99 Screening test for hormone sensitivity by the autoradiographic method using cell mats. Am J Clin Oncol 1990 0.75
100 Survival following resection for lung cancer as a second primary cancer. Int Surg 1996 0.75
101 Confluent BALB/c 3T3 cells monolayer provides selective and efficient growth of neoplastic cells. Cancer Lett 1990 0.75
102 The sensitivity of hyperthermo-chemo-radiotherapy for neoplastic cells in vitro on contact-sensitive plates. Eur J Surg Oncol 1993 0.75
103 [A case of postoperative hyponatremia caused by Sheehan syndrome associated with lung carcinoma]. J UOEH 1995 0.75
104 Aspergilloma within cavitating pulmonary carcinoma. Case report. Scand J Thorac Cardiovasc Surg 1993 0.75
105 The close relationship between growth factors and the nucleolar organizer regions in adenocarcinoma of the lung. Eur J Surg Oncol 1995 0.75
106 Combined carboplatin and cisplatin therapy in patients with advanced non-small cell lung cancer. Am J Clin Oncol 1997 0.75
107 [A carcinoma arising from benign pleomorphic adenoma of the trachea]. Kyobu Geka 1997 0.75
108 Phenotypic characterization of lymphokine-activated killer cells from human lymph node lymphocytes. Cell Immunol 1989 0.75
109 Nucleolar organizer regions are independently associated with a shortened survival in patients with non-small cell lung cancer. Surg Oncol 1993 0.75
110 [Expression of CD44 alternative splicing variants in lung cancer]. Nihon Rinsho 1995 0.75
111 Combined thoracoscopy and mediastinoscopy for the evaluation of mediastinal lymph node metastasis in left upper lobe lung cancer. J Cardiovasc Surg (Torino) 1994 0.75
112 Proliferating cell nuclear antigen and argyrophilic nucleolar organizer regions in patients with thymic disease. Oncol Rep 2011 0.75
113 Aggressive pulmonary metastasectomies for synovial sarcoma. Respiration 1997 0.75